Tetrabuthylammonium

Tetrabuthylammonium

SCHEMBL466

CCCC[N+](CCCC)(CCCC)CCCC.[F-]

nearest known ligand 0.92

Full drug profile on Sugi Atlas →

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
SLC22A1 O15245 4/20 0.92
SLC22A2 O15244 1/20 0.79
TSHR P16473 2/20 0.69
ALDH1A1 P00352 1/20 0.69
TP53 P04637 1/20 0.69
CYP3A4 P08684 1/20 0.69
ALOX15 P16050 1/20 0.69
ALOX12 P18054 1/20 0.69
SMN1; SMN2 Q16637 1/20 0.69
HIF1A Q16665 1/20 0.69
HSD17B10 Q99714 1/20 0.69
DNM1 Q05193 6/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Tetrabuthylammonium SCHEMBL226110 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL28519848 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL5144255 1.00 SLC22A1 (0.92) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL9416676 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL2123749 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL25325582 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL2705733 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL4056559 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL6622741 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53
Tetrabuthylammonium SCHEMBL5484505 0.96 SLC22A1 (0.86) SLC22A1SLC22A2TSHRALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Appears in 112840 patents — a generic fragment claimed broadly, so it's down-weighted as IP noise. Top by claim status then date:

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4747300-A1 ON-SUBSTRATE MIXING NANIZE AS (NO) 2026-05-27 EP claimed
CN-117229145-B Industrial chemical preparation method of 1, 2-diglyceride Guangzhou Baiyunshan Hanfang Modern Pharmaceutical Co.,Ltd. (CN) 2026-05-26 CN claimed
CN-119751529-B Nucleotide dimer, preparation method and application thereof Beijing Xuanjingrui Pharmaceutical Technology Co.,Ltd. (CN) 2026-05-26 CN claimed
US-12637469-B2 1H-pyrazole derivative and application thereof as dual target inhibitor of Syk and VEGFR2 OCUMENSION THERAPEUTICS (SUZHOU) CO., LTD. (CN) 2026-05-26 US claimed
US-12637616-B2 Etching solution for selectively removing silicon-germanium alloy from a silicon-germanium/ silicon stack during manufacture of a semiconductor device VERSUM MATERIALS US, LLC (US) 2026-05-26 US claimed
CN-122080553-A High-temperature-resistant sealing rubber material and preparation method thereof 2026-05-26 CN claimed
CN-122071484-A Mononuclear NNN type divalent Cu-F metal complex, preparation method, intermediate and application thereof 中国科学院上海有机化学研究所 2026-05-22 CN claimed
CN-122071483-A Binuclear NNN type divalent Cu-F metal complex, preparation method, intermediate and application thereof 中国科学院上海有机化学研究所 2026-05-22 CN claimed
CN-117143592-B Mn (Mn)4+Activated fluoride (oxide) red fluorescent material and preparation method thereof 华南理工大学 2026-05-22 CN claimed
CN-117126138-B Compound for degrading target protein in ubiquitin-proteasome system, and preparation method and application thereof 深圳湾实验室坪山生物医药研发转化中心 2026-05-22 CN claimed
EP-0061761-A1 A method for preparing a mononucleotide-3'-phosphodiester-based substrate Baker Instruments Corporation (US) 1982-10-06 EP claimed
EP-0059094-A1 Novel cycloheptanes ORTHO PHARMACEUTICAL CORPORATION (US) 1982-09-01 EP claimed
EP-0054795-A2 Novel halogenated prostacyclins, process for the production thereof, and pharmaceutical use thereof TEIJIN LIMITED (JP) 1982-06-30 EP claimed
US-4296035-A Total synthesis of the utero-evacuant substance d,l-zoapatanol ORTHO PHARMACEUTICAL CORPORATION (US) 1981-10-20 US claimed
EP-0033536-A2 6(R)-(2-(8'-etherified-hydroxy-2',6'-dimethylpolyhydro-naphthyl-1')-ethyl)-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones, the hydroxy acid form of said pyranones, the salts of said acid form, process for preparing the same and an antihypercholesterolemic pharmaceutical composition containing the same MERCK & CO. INC. (US) 1981-08-12 EP claimed
EP-0033538-A2 6(R)-(2-(8'-acyloxy-2'-methyl-6'-methyl (or hydrogen)-polyhydronaphthyl-1')-ethyl)-4(R)-hydroxy-3,4,5,6-tetrahydro-2H-pyran-2-ones, the hydroxy acid form of said pyranones, the pharmaceutically acceptable salts of said hydroxy acids, and the lower alkyl, and phenyl, dimethylamino or acetylamino substituted lower alkyl esters of said hydroxy acid, processes for preparing the same, and a pharmaceutical antihypercholesterolemic composition containing the same MERCK & CO. INC. (US) 1981-08-12 EP claimed
US-4252970-A MULTISTEP PROCESS, ONE STEP IS DESULFONATION OF 6-SULFONYLNEAMINES TO FORM 5,6-DIDEOXY-5-OXONEAMINES THE UPJOHN COMPANY (US) 1981-02-24 US claimed
US-4237053-A Total synthesis of the utero-evacuant substance d,l-zoapatanol ORTHO PHARMACEUTICAL CORPORATION (US) 1980-12-02 US claimed
EP-0005308-A1 Process for the interconversion of intermediates of use in the preparation of prostaglandins ALLEN & HANBURYS LIMITED (GB) 1979-11-14 EP claimed
US-4140850-A IMMUNOSUPPRESSIVE, VIRICIDES, SILYLATION, CYCLIZATION, DESILYLATION THE UPJOHN COMPANY (US) 1979-02-20 US claimed